Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2003 2
2004 3
2005 2
2006 7
2007 4
2008 5
2009 6
2010 9
2011 10
2012 10
2013 7
2014 15
2015 12
2016 15
2017 15
2018 11
2019 7
2020 6
2021 7
2022 11
2023 6
2024 10
2025 7
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Results by year

Filters applied: . Clear all
Page 1
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement.
Domínguez J, Boeree MJ, Cambau E, Chesov D, Conradie F, Cox V, Dheda K, Dudnyk A, Farhat MR, Gagneux S, Grobusch MP, Gröschel MI, Guglielmetti L, Kontsevaya I, Lange B, van Leth F, Lienhardt C, Mandalakas AM, Maurer FP, Merker M, Miotto P, Molina-Moya B, Morel F, Niemann S, Veziris N, Whitelaw A, Horsburgh CR Jr, Lange C; TBnet and RESIST-TB networks. Domínguez J, et al. Among authors: veziris n. Lancet Infect Dis. 2023 Apr;23(4):e122-e137. doi: 10.1016/S1473-3099(22)00875-1. Epub 2023 Feb 28. Lancet Infect Dis. 2023. PMID: 36868253 Free PMC article. Review.
Bedaquiline Activity against Leprosy.
Fomba A, Haidara FC, Kodio M, Arama C, Cambau E, Chauffour A, Veziris N, Broeckling BE, Warren AK, Cauchoix B, Alcaïs A, Marsollier L, Assé H, Jackson M, Sow SO, Faye O, Jarlier V, Cole ST, Avanzi C, Aubry A, Johnson RC. Fomba A, et al. Among authors: veziris n. N Engl J Med. 2025 Jun 5;392(21):2174-2176. doi: 10.1056/NEJMc2412487. N Engl J Med. 2025. PMID: 40466073 Free PMC article. No abstract available.
[Tuberculosis: New findings on an old infectious disease].
Aubry A, Veziris N. Aubry A, et al. Among authors: veziris n. Med Sci (Paris). 2023 Mar;39(3):203-204. doi: 10.1051/medsci/2023054. Epub 2023 Mar 21. Med Sci (Paris). 2023. PMID: 36943114 Free article. French. No abstract available.
[Managing multidrug-resistant tuberculosis].
Antoun F, Véziris N. Antoun F, et al. Among authors: veziris n. Rev Mal Respir. 2011 Oct;28(8):956-7. doi: 10.1016/j.rmr.2011.06.010. Epub 2011 Oct 12. Rev Mal Respir. 2011. PMID: 22099400 French. No abstract available.
[Molecular diagnosis of tuberculosis].
Morel F, Jaffré J, Sougakoff W, Aubry A, Véziris N. Morel F, et al. Among authors: veziris n. Rev Mal Respir. 2020 May;37(5):412-416. doi: 10.1016/j.rmr.2019.09.004. Epub 2020 Apr 22. Rev Mal Respir. 2020. PMID: 32334967 Free article. Review. French.
[Resistance to antituberculous drugs].
Veziris N, Cambau E, Sougakoff W, Robert J, Jarlier V. Veziris N, et al. Arch Pediatr. 2005 Aug;12 Suppl 2:S102-9. doi: 10.1016/s0929-693x(05)80024-7. Arch Pediatr. 2005. PMID: 16129320 Review. French.
Multidrug and extensively drug-resistant tuberculosis.
Maitre T, Aubry A, Jarlier V, Robert J, Veziris N; CNR-MyRMA. Maitre T, et al. Among authors: veziris n. Med Mal Infect. 2017 Feb;47(1):3-10. doi: 10.1016/j.medmal.2016.07.006. Med Mal Infect. 2017. PMID: 27637852 Review.
168 results